Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-06-18
1986-07-01
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549263, 549328, 514909, 435123, 435886, C07D30512, C12P 1702, A61K 31365
Patent
active
045980896
ABSTRACT:
Novel compounds of the formula ##STR1## wherein A signifies the group ##STR2## or --(CH.sub.2).sub.5 --, which inhibit pancreas lipase and can be used for the control or prevention of obesity and hyperlipaemia, are disclosed. The inventive compounds can be produced by the cultivation of microorganism Streptomyces toxytricini, identified as NRRL 15443.
REFERENCES:
patent: 4189438 (1980-02-01), Umezawa et al.
patent: 4202824 (1980-05-01), Umezawa et al.
patent: 4242453 (1980-12-01), Umezawa et al.
patent: 4358602 (1982-11-01), Umezawa et al.
Derwent 70402 D/39 (Mar. 1980).
Derwent 87970 B/49 (May 1978).
Hadvary Paul
Hochuli Erich
Kupfer Ernst
Lengsfeld Hans
Weibel Ernst K.
Dinner Dara
Hoffmann-La Roche Inc.
Hollrah Glennon H.
Johnston George W.
Leon Bernard S.
LandOfFree
Leucine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leucine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leucine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1082770